Low Testosterone Isn't Always a TRT Problem: Understanding Your Options

If you've looked into low testosterone treatment, you've probably run into the assumption that low T automatically means testosterone replacement therapy (TRT). It's a reasonable assumption, TRT works, it's well established, and it's the most talked-about option. But it's not the only question worth asking, and for some men, it's not even the first one.

The more useful starting point is: why is testosterone low in the first place?

Testosterone Doesn't Operate in Isolation

Testosterone production is governed by the hypothalamic-pituitary-gonadal (HPG) axis, the communication loop between your brain and your testes that regulates how much testosterone your body makes. The hypothalamus signals the pituitary, the pituitary signals the testes, and the testes respond by producing testosterone. When that signaling breaks down or gets suppressed, total testosterone drops.

The catch is that a lot of common, everyday factors can suppress this signaling without anything being structurally "wrong" with the testes themselves:

• Poor sleep — much of your daily testosterone release is tied to sleep architecture; chronically short or fragmented sleep blunts it

• Chronic stress — sustained cortisol elevation interferes with HPG signaling

• Overtraining and under-recovery — too much training stress without adequate recovery can suppress the same axis

• Increased visceral fat — fat tissue converts testosterone into estrogen via the aromatase enzyme, and visceral fat is particularly active in this conversion

• Poor nutrition — chronic caloric deficits or certain dietary patterns can lower production

• Metabolic dysfunction — insulin resistance and related conditions are strongly associated with lower testosterone

  
  

This category is often called functional hypogonadism: testosterone is low, but it's secondary to something else that's disrupting the signal, not a primary failure of the testes or pituitary. And functional causes are, at least in theory, reversible, which changes the conversation from "how do we replace what's missing" to "can we restore what's being suppressed."

That distinction matters because TRT and the alternative approaches don't do the same thing.

Why "Just Start TRT" Isn't the Only Answer

TRT raises testosterone by supplying it externally. It's effective and well studied, but it works by overriding the HPG axis, not restoring it. The brain senses adequate testosterone from the injection or gel, dials back its own signal to the testes, and natural production declines, along with sperm production. This is precisely why men trying to preserve or restore fertility are generally advised against starting TRT.

For those men, one alternative that's been explored is enclomiphene, a selective estrogen receptor modulator (SERM). Rather than supplying testosterone, it blocks estrogen receptors in the hypothalamus, which increases the release of gonadotropin-releasing hormone, prompting the body's own machinery to produce more testosterone and supporting ongoing sperm production in the process.

A 2025 systematic review and meta-analysis in Archives of Endocrinology and Metabolism pooled data from 10 randomized controlled trials (819 men total) comparing SERMs (clomiphene or enclomiphene) against placebo, testosterone gel, or hCG. A few things stood out:

• SERM therapy raised total testosterone substantially compared to placebo, and produced testosterone levels statistically similar to topical testosterone gel.

• Compared to testosterone gel, SERM therapy was associated with significantly better preservation of sperm concentration, gel use was linked to a meaningful drop in sperm parameters, while SERM use was not.

• Adverse events were generally mild and comparable across groups, though the review notes a small number of cases involving elevated PSA or hematocrit that led to discontinuation, and flags that the body of safety data remains underpowered overall.

  
  

It's worth being honest about the caveats here too. The testosterone-level findings showed high statistical heterogeneity across studies, follow-up periods were mostly short (2 to 30 weeks), two of the ten trials were rated high risk of bias, and the certainty of evidence was graded moderate to low across the board, not high. This is a meaningful and growing body of research, not a settled, slam-dunk case, and the review's own authors frame SERM therapy as a viable alternative to consider, not a universal replacement for TRT.

The Goal Isn't a Number on a Lab Report

It's easy to fixate on getting total testosterone into a specific range. But a lab value isn't the actual goal, it's a proxy for things that are. The better measures of success are usually:

• Improved symptoms (energy, mood, libido, recovery)

• Better body composition

• Overall metabolic and physical health

• A plan that accounts for your specific situation, age, fertility goals, comorbidities, and the underlying reason testosterone is low

  
  

For some men, that plan is TRT, and TRT can be exactly the right call. For others, particularly younger men, men actively trying to conceive, or men whose low T looks more functional than structural, addressing root causes or considering a SERM-based approach may make more sense.

Who Might Not Be a Good Candidate for TRT or Enclomiphene

Neither option is appropriate for everyone, and a few factors generally warrant extra caution or rule a treatment out:

For TRT, caution is generally warranted with:

• Active fertility goals (TRT suppresses sperm production)

• Untreated or poorly controlled sleep apnea

• Significantly elevated hematocrit or a history of polycythemia

• Active or suspected prostate or breast cancer

• Severe untreated heart failure

• Desire to avoid lifelong dependence on exogenous hormone, since stopping TRT typically requires a recovery period for natural production to resume

  
  

For enclomiphene/SERMs, caution is generally warranted with:

• A history of blood clots or thromboembolic disease

• Visual disturbances or pre-existing eye conditions (some SERMs are associated with visual side effects)

• Liver disease

• Hypersensitivity to the medication class

• Hypogonadism caused by a structural problem, like a pituitary tumor or primary testicular failure, rather than a functional, reversible cause, since SERMs work by stimulating a system that needs to still be capable of responding

  
  

This is exactly why hormone optimization isn't a one-size-fits-all decision. The right starting point depends on your labs, your goals, your health history, and what's actually driving your testosterone down, which is a conversation to have with a physician who can evaluate your full picture, not a protocol to self-select based on a single number.

Currently treating patients located in:

Colorado, Florida, Hawaii, and Washington!

Click the link to schedule a consultation today!

https://mana-loa.clientsecure.me

-The Mana Loa Health Team

Patient safety is Mana Loa Health's top priority. The information discussed on this blog is not intended to recommend the self management of health problems or wellness. It is not intended to endorse or recommend any particular type of medical treatment or advice. The information provided on this website is for informational purposes and not a substitute for professional medical advice, diagnosis, or treatment. If you have questions or concerns about your health, please talk to your healthcare provider. No information contained on this blog should be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider.

Reference

Source: Hohl A, Chavez MP, Pasqualotto E, et al. Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials. Arch Endocrinol Metab. 2025;69(5):e250093.